KANE MATTHEW R. 4
4 · PRECISION BIOSCIENCES INC · Filed Apr 12, 2021
Insider Transaction Report
Form 4
KANE MATTHEW R.
DirectorPresident and CEO10% Owner
Transactions
- Exercise/Conversion
Common Stock
2021-04-09$0.04/sh+21,514$861→ 1,962,760 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-04-08−21,514→ 107,570 totalExercise: $0.04Exp: 2021-05-17→ Common Stock (21,514 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2021-04-09−21,514→ 86,056 totalExercise: $0.04Exp: 2021-05-17→ Common Stock (21,514 underlying) - Sale
Common Stock
2021-04-08$9.00/sh−9,736$87,624→ 1,941,246 total - Sale
Common Stock
2021-04-09$8.87/sh−9,737$86,367→ 1,953,023 total - Exercise/Conversion
Common Stock
2021-04-08$0.04/sh+21,514$861→ 1,950,982 total
Holdings
- 10,841(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]All sales were effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover the option exercise price and taxes, and the reporting person retaining all remaining shares.
- [F2]Shares are held by Chelsea Lynam Kane, the spouse of the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- [F3]The option is fully vested and exercisable.